Related Experiment Video
Updated: Dec 23, 2025

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Use of Taxanes in Metastatic HER2-negative Breast Cancer - a Status Report
Oleg Gluz1,2,3, Cornelia Kolberg-Liedtke4, Frederik Marmé5
1Westdeutsche Studiengruppe, Mönchengladbach, Germany.
Abstract:
The most important goal of treatment of patients with metastatic breast cancer is maintenance or even improvement of quality of life. In this setting, chemotherapy should be used with as much restraint as possible. If palliative chemotherapy is indicated, the taxane drug class is an established treatment option. The updated guidelines of the Gynaecological Oncology Working Group (AGO), Breast Committee, of the German Society for Gynaecology and Obstetrics (DGGG) and the German Cancer Society e. V. (DKG) provide recommendations with the greatest possible evidence on which of the licensed taxanes can be used in which treatment situation in the metastatic setting.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Treatment Resistant Cancers
Tumor Immunotherapy

